Compound Q&A
What is the market or research trend for Alectinib (CAS: 1256580-46-7)?
Answer
The market for Alectinib is growing due to its efficacy in treating ALK-positive non-small cell lung cancer. Research trends focus on its use in combination therapies and its potential in treating other cancers. Market trends also reflect increasing demand for precision oncology treatments.
About
CAS No
1256580-46-7
English Name
Alectinib
Molecular Formula
C30H34N4O2
Molecular Weight
482.62 g/mol
SMILES
CCc1cc2C(=O)c3c([nH]c4cc(C#N)ccc34)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6
InChIKey
KDGFLJKFZUIJMX-UHFFFAOYSA-N
Last Updated: 2025-09-08 18:31
